Compare Eaton Corporation plc (ETN) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Repligen Corporation Common Stock — how do they compare? Eaton Corporation plc trades at $399.45 (market cap $166.36B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Eaton Corporation plc is far larger — about 14.9× Repligen Corporation Common Stock's market cap, and Eaton Corporation plc pays a 1.03% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 32 Days and Repligen Corporation Common Stock for 0 Days on average.
| ETN | RGEN | |
|---|---|---|
Market Cap | $166.36B | $11.14B |
Volume | 1,762,788 | 1,259,263 |
Sector | Industrials | Health |
52-Week High | $459.96 | $194.57 |
52-Week Low | $315.82 | $102.87 |
Typical Hold Time | 32 Days | 0 Days |
Enterprise Value | $186.99B | $11.02B |
Dividend Yield | 1.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eaton (ETN) trades at $428.31, up 0.38% on the day, with a neutral technical signal and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Strong profitability is evident with a net income margin of 12.75% and ROE of 19.71%. Recent news highlights growth from data center and aerospace demand, supported by strategic acquisitions like COL Group (Business Wire, 2026-09-25).
The outlook remains positive given analyst consensus with a $502.38 price target and 70% buy ratings. Key opportunities include exposure to AI-driven data center expansion and grid modernization. Risks involve execution of acquisitions, competitive pressures, and macroeconomic sensitivity. Valuation multiples like a P/E of 43.62 suggest premium pricing relative to earnings growth.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
